Alloimmune Thrombocytopenia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-04-30
Clinical Trial Update: An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia [EARLY_Phase 1]
This clinical trial is an early-phase study evaluating CD19 CAR NK cells for treating refractory primary immune thrombocytopenia (alloimmune…